Price $16.85 |
Market Cap
511.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
45.63
|
P/S
12.23
|
Dividend %
-
|
|
P/CF
118.3
|
P/FCF
-
|
Op. Cash Flow
-10.5K
|
FCF
-0.3
|
|
Op. Margin
-19.30%
|
Net Margin
-32.00%
|
ROE
-187.40%
|
ROI
-
|
|
ROA
-38.10%
|
EPS Growth
5.40%
|
Current Ratio
4.0
|
Debt/Equity
136.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.22 | - | - | 9.8M | Strong Buy |
| Momenta Pharmaceuticals, Inc. (MNTA) | $16.90 | - | - | 1.27B | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.46 | - | - | 4M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.48 | - | - | 83.4M | Strong Buy |
| BioLife Solutions Inc (BLFS) | $3.34 | - | - | 30.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
